Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lahousen

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Treatment of primary cancer of the fallopian tube]B Pakisch, J Poschauko, G Stücklschweiger, et al.
Archives of Gynecology and Obstetrics|January 1, 1994
Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinomaA C Rosen, M Klein, H R Rosen, et al.
Oncology|January 1, 1997
A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapyA du Bois, C J McKenna, H Andersson, et al.
Gynecologic Oncology|October 1, 1990
Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary reportK S Arian-Schad, D S Kapp, A Hackl, et al.
Cancer|January 21, 2000
The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesP Felsner, W Steinschifter, M Fischer, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1993
[Primary fallopian tube cancer--an Austrian multicenter study]A Rosen, M Klein, M Lahousen, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
Cancer|October 3, 2000
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter studyL A Hefler, A C Rosen, A H Graf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinomaL S Hofstra, G B Kristensen, P H Willemse, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Treatment of primary cancer of the fallopian tube]B Pakisch, J Poschauko, G Stücklschweiger, et al.
Archives of Gynecology and Obstetrics|January 1, 1994
Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinomaA C Rosen, M Klein, H R Rosen, et al.
Oncology|January 1, 1997
A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapyA du Bois, C J McKenna, H Andersson, et al.
Gynecologic Oncology|October 1, 1990
Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary reportK S Arian-Schad, D S Kapp, A Hackl, et al.
Cancer|January 21, 2000
The tumor-associated shift in immunoglobulin G1/G2 is expressed at the messenger RNA level of peripheral blood B lymphocytes in patients with gynecologic malignanciesP Felsner, W Steinschifter, M Fischer, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1993
[Primary fallopian tube cancer--an Austrian multicenter study]A Rosen, M Klein, M Lahousen, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
Cancer|October 3, 2000
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter studyL A Hefler, A C Rosen, A H Graf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinomaL S Hofstra, G B Kristensen, P H Willemse, et al.
Pageof 9